Integramed America, Inc. (INMD) Tops Q4 EPS by 3c, Sales Top Consensus

Integramed America, Inc. (NASDAQ: INMD) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $70.88 million versus the consensus estimate of $69.58 million.

For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c